UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine, 2022-03, Vol.40 (10), p.1499-1511

2022

Volltextzugriff (PDF)

Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting System

Vaccine, 2014-08, Vol.32 (37), p.4758-4765

2014

Volltextzugriff (PDF)

International Consensus (ICON): allergic reactions to vaccines

The World Allergy Organization journal, 2016-09, Vol.9 (1), p.32-32, Article 32

2016

Volltextzugriff (PDF)

Humoral responses to independent vaccinations are correlated in healthy boosted adults

Vaccine, 2014-09, Vol.32 (43), p.5624-5631

2014

Volltextzugriff (PDF)

Select Human Anthrax Protective Antigen Epitope-Specific Antibodies Provide Protection from Lethal Toxin Challenge

The Journal of infectious diseases, 2010-07, Vol.202 (2), p.251-260

2010

Volltextzugriff (PDF)

Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacity

Vaccine, 2011-05, Vol.29 (20), p.3670-3678

2011

Volltextzugriff (PDF)

Myopericarditis following Smallpox Vaccination

American journal of epidemiology, 2004-10, Vol.160 (7), p.642-651

2004

Volltextzugriff (PDF)

Complementary and alternative medicine for the allergist-immunologist: Where do I start?

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.309-316.e4

2009

Volltextzugriff (PDF)

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

Vaccine, 2017-06, Vol.35 (26), p.3416-3422

2017

Volltextzugriff (PDF)

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

Pediatrics (Evanston), 2008-09, Vol.122 (3), p.e771

2008

Volltextzugriff (PDF)

Severe Postvaccinia Encephalitis with Acute Disseminated Encephalomyelitis: Recovery with Early Intravenous Immunoglobulin, High-Dose Steroids, and Vaccinia Immunoglobulin

Clinical infectious diseases, 2009-02, Vol.48 (4), p.e47-e49

2009

Volltextzugriff (PDF)

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification

Obesity (Silver Spring, Md.), 2015-06, Vol.23 (6), p.1312-1319

2015

Volltextzugriff (PDF)

Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals

Microorganisms (Basel), 2021-06, Vol.9 (6), p.1204

2021

Volltextzugriff (PDF)

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

Journal of allergy and clinical immunology, 2002-09, Vol.110 (3), p.357-365

2002

Volltextzugriff (PDF)

Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination

Clinical and vaccine immunology, 2016-08, Vol.23 (8), p.664-671

2016

Volltextzugriff (PDF)

Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges

Annals of allergy, asthma, & immunology, 2020-07, Vol.125 (1), p.2-3

2020

Volltextzugriff (PDF)

Protective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunity

Toxins, 2014-08, Vol.6 (8), p.2424-2431

2014

Volltextzugriff (PDF)

Immunization to protect the US Armed Forces: heritage, current practice, and prospects

Epidemiologic reviews, 2006-01, Vol.28 (1), p.3-26

2006

Volltextzugriff (PDF)

Myocarditis and pericarditis recovery following smallpox vaccine 2002-2016: A comparative observational cohort study in the military health system

PloS one, 2023-05, Vol.18 (5), p.e0283988-e0283988

2023

Volltextzugriff (PDF)

Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients

Clinical and vaccine immunology, 2017-11, Vol.24 (11)

2017

Volltextzugriff (PDF)

Complementary and alternative medicine education: Need for expanded educational resources for American Academy of Allergy, Asthma & Immunology members

Journal of allergy and clinical immunology, 2009-02, Vol.123 (2), p.511-512

2009

Volltextzugriff (PDF)

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network

Pediatrics (Evanston), 2011-05, Vol.127 Suppl 1, p.S65

2011

Volltextzugriff (PDF)

Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination

Journal of the American College of Cardiology, 2004-07, Vol.44 (1), p.201-205

2004

Volltextzugriff (PDF)

Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44years reported to the Vaccine Adverse Event Reporting System

Vaccine, 2016-08, Vol.34 (37), p.4406-4414

2016

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(83)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Ischemic cardiac events and other adverse events following ACAM2000® smallpox vaccine in the Vaccine Adverse Event Reporting System

International Consensus (ICON): allergic reactions to vaccines

Humoral responses to independent vaccinations are correlated in healthy boosted adults

Select Human Anthrax Protective Antigen Epitope-Specific Antibodies Provide Protection from Lethal Toxin Challenge

Anthrax vaccination induced anti-lethal factor IgG: Fine specificity and neutralizing capacity

A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination

Myopericarditis following Smallpox Vaccination

Complementary and alternative medicine for the allergist-immunologist: Where do I start?

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

Severe Postvaccinia Encephalitis with Acute Disseminated Encephalomyelitis: Recovery with Early Intravenous Immunoglobulin, High-Dose Steroids, and Vaccinia Immunoglobulin

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification

Insufficient Anthrax Lethal Toxin Neutralization Is Associated with Antibody Subclass and Domain Specificity in the Plasma of Anthrax-Vaccinated Individuals

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination

Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges

Protective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunity

Immunization to protect the US Armed Forces: heritage, current practice, and prospects

Myocarditis and pericarditis recovery following smallpox vaccine 2002-2016: A comparative observational cohort study in the military health system

Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients

Complementary and alternative medicine education: Need for expanded educational resources for American Academy of Allergy, Asthma & Immunology members

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network

Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination

Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009–2010 season in the active component U.S. military and civilians aged 17–44years reported to the Vaccine Adverse Event Reporting System

Suchergebnisse filtern